Home NDC 57844-510 Adasuve
Product NDC 57844-510
11-digit product format 578440510
Labeler code 57844
Product ID 57844-510_f34da003-6601-4cf7-8036-b65d3c6606ea
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name loxapine
Dosage form AEROSOL, POWDER
Route RESPIRATORY (INHALATION)
Labeler Teva Select Brands
Application NDA022549
Marketing category NDA
Marketing start 2014-01-22
Marketing end 0000-00-00
Substance LOXAPINE
Active strength 10 mg/1
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 57844-510-55 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 57844-510-55 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 57844-510-55 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 57844-510-55 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 57844-510-55 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 57844-510-55 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 57844-510-55 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 57844-510-55 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 57844-510-55 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 57844-510-55 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 57844-510-55 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 57844-510-55 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022549-001 ADASUVE LOXAPINE 10MG POWDER / INHALATION RLD, RS 2012-12-21
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022549-001 8387612 2026-10-23 Drug product 2013-03-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022549-001 ADASUVE 10MG POWDER / INHALATION RLD, RS 2012-12-21 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 8 · 316 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 9370629 2024-05-20 Drug product 2016-07-07 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 8991387 2024-05-21 Drug product 2015-04-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 7458374 2024-08-18 Drug product 2013-03-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 7537009 2024-10-28 Drug product 2013-03-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022549-001 8387612 2026-10-23 Drug product 2013-03-29 301d65b070ca…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Adasuve LOXAPINE Alexza Pharmaceuticals, Inc. 50e11732-7387-452d-b3e6-db3a431d5c4a 2026-07-06 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022549 application number: NDA022549